Solid Earnings, Modest Buyback Fail to Boost Drug Seller 111 Inc.
Key takeaways:
111’s revenue grew 87% in second quarter, generally outpacing its peers, as it aims to more than double its fulfillment capacity this year
Company’s shares now trade around $6.50, well off a $23 high reached in February, as investors worry about regulatory wave for broader tech sector
By Mia Shanley